Biodim

Biodim is a French pharmaceutical company that specializes in the acquisition and commercialization of established, "mature" medical brands. Since its acquisition by Mayoly in 2021, the company has served as a key pillar for the group's presence in the psychiatry and gynecology markets. Biodim manages a portfolio of well-known legacy drugs, ensuring their continued distribution and medical support within the French healthcare system. Its business model focuses on life-cycle management rather than early-stage drug discovery. The company's portfolio includes prominent brands such as Tercian for anxiety and Colpotrophine for gynecological health. By maintaining these essential therapies, Biodim provides critical support to healthcare professionals and patients across France.